Distinguishing diabetic nephropathy from other causes of glomerulosclerosis: an update

被引：181

作者：

Alsaad, K. O. ^{[1
]}

Herzenberg, A. M. ^{[1
]}

机构：

[1] UHN, Princess Margaret Hosp, Toronto, ON M5G 2M9, Canada

来源：

JOURNAL OF CLINICAL PATHOLOGY | 2007年 / 60卷 / 01期

关键词：

D O I：

10.1136/jcp.2005.035592

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

Diabetic nephropathy is a common cause of end-stage renal disease worldwide. It is characterised by diffuse or nodular glomerulosclerosis, afferent and efferent hyaline arteriolosclerosis, and tubulointerstitial fibrosis and atrophy. Diffuse and nodular diabetic glomerulosclerosis share similar histological features with other clinical conditions. Immunofluorescence and electron microscopy studies, and clinicopathological correlation are essential to differentiate diabetic nephropathy from other conditions that result in diffuse and nodular glomerulosclerosis.

引用

页码：18 / 26

页数：9

共 36 条

[1] Membranoproliferative glomerulonephritis type II (dense deposit disease):: An update [J].

Appel, GB ;

Cook, HT ;

Hageman, G ;

Jennette, JC ;

Kashgarian, M ;

Kirschfink, M ;

Lambris, JD ;

Lanning, L ;

Lutz, HU ;

Meri, S ;

Rose, NR ;

Salant, DJ ;

Sethi, S ;

Smith, RJH ;

Smoyer, W ;

Tully, HF ;

Tully, SP ;

Walker, P ;

Welsh, M ;

Würzner, R ;

Zipfel, PF .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (05) :1392-1403

[2] FAMILIAL GLOMERULONEPHRITIS CHARACTERIZED BY MASSIVE DEPOSITS OF FIBRONECTIN [J].

ASSMANN, KJM ;

KOENE, RAP ;

WETZELS, JFM .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 25 (05) :781-791

[3] The clinical and morphologic spectrum of renal cryoglobulinemia [J].

Beddhu, S ;

Bastacky, S ;

Johnson, JP .

MEDICINE, 2002, 81 (05) :398-409

[4] Diabetic nephropathy:: An inherited disease or just a diabetic complication? [J].

Berger, M ;

Mönks, D ;

Wanner, C ;

Lindner, TH .

KIDNEY & BLOOD PRESSURE RESEARCH, 2003, 26 (03) :143-154

[5] Fibrillary glomerulonephritis and immunotactoid (microtubular) glomerulopathy are associated with distinct immunologic features [J].

Bridoux, F ;

Hugue, V ;

Coldefy, O ;

Goujon, JM ;

Bauwens, M ;

Sechet, A ;

Preud'Homme, JL ;

Touchard, G .

KIDNEY INTERNATIONAL, 2002, 62 (05) :1764-1775

[6] Biochemistry and molecular cell biology of diabetic complications [J].

Brownlee, M .

NATURE, 2001, 414 (6865) :813-820

[7] Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes [J].

Dalla Vestra, M ;

Masiero, A ;

Roiter, AM ;

Saller, A ;

Crepaldi, G ;

Fioretto, P .

DIABETES, 2003, 52 (04) :1031-1035

[8] Apheresis in cryoglobulinemia complicating hepatitis C and in other renal diseases [J].

Dominguez, JH ;

Sha, E .

THERAPEUTIC APHERESIS, 2002, 6 (01) :69-76

[9] The early natural history of nephropathy in type 1 diabetes - II. Early renal structural changes in type 1 diabetes [J].

Drummond, K ;

Mauer, M .

DIABETES, 2002, 51 (05) :1580-1587

[10]

Estacio R O, 2001, Adv Intern Med, V46, P359

← 1 2 3 4 →